Streetbeat News

Revenues

IPWR

Ideal Power (NASDAQ:IPWR) reported Q2 EPS of $(0.31), an improvement from $(0.37) YoY, but missed sales estimates significantly with $1.33K against the expected $100.00K.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:23 pm

BABA

PNQI

SE

XNTK

Alibaba's Lazada achieved its first monthly profit in July 2024, driven by AI-enabled operations and improved logistics. Despite this, Lazada faces strong competition from Sea Limited's Shopee. Alibaba's international commerce retail business saw a 45% revenue increase in Q4, but its stock has declined over the past year due to domestic challenges.

Portfolio Pulse from Anusuya Lahiri

August 14, 2024 | 1:23 pm

MPTI

M-Tron Industries (AMEX:MPTI) reported Q2 earnings per share of $0.63, beating the analyst estimate of $0.50 by 26%. Sales were $11.81M, surpassing the $11.20M estimate and marking a 16.45% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:17 pm

CRKN

Crown Electrokinetics has reiterated its Q3 revenue forecast of $8.0 million.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:13 pm

GLASF

Glass House Brands (OTC:GLASF) reported a record Q2 2024 with $53.9 million in revenue, a 21% YoY increase. Gross profits rose to $28.7 million, and adjusted EBITDA improved to $12.4 million. Despite a net loss of $10 million, the company projects Q3 revenue between $65 million and $67 million.

Portfolio Pulse from Nicolás Jose Rodriguez

August 14, 2024 | 1:13 pm

CRKN

Crown ElectroKinetics (NASDAQ:CRKN) reported a Q2 GAAP EPS loss of $(5.89) per share, a significant increase from the $(2.72 thousand) per share loss YoY. Sales rose to $4.65 million, a 12.46K percent increase from $37.00 thousand YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:11 pm

ELAB

Elevai Labs (NASDAQ:ELAB) reported a Q2 EPS of $(0.08), an improvement from $(0.13) YoY, and sales of $605.53K, up 91.30% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:10 pm

INVO

INVO BioScience reported a Q2 EPS of $(0.62), an improvement from $(3.06) year-over-year. Revenue increased to $1.826 million from $315,902 YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:08 pm

ELAB

Elevai Labs reported Q2 sales of $605K.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:07 pm

CRKN

Crown ElectroKinetics (NASDAQ:CRKN) reported Q2 losses of $(5.89) per share, a significant increase from $(2.72 thousand) per share last year. Sales rose to $4.65 million, a 12.46K percent increase from $37.00 thousand YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:06 pm